About University of California at Irvine Medical Center; Department of Oncology
"We are UCI Health: A devoted team of nationally regarded physicians and nurses, researchers and clinicians, educators and students united by a single calling to improve the lives of the people in our community and beyond. As the only academic health system in Orange County, our multifaceted organization is dedicated to the discovery of new medical frontiers, to the teaching of future healers and to the delivery of the finest evidence-based care. We are unique in our ability to provide the most compassionate healthcare because were driven by our passion for innovation, grounded in the best medical and scientific knowledge."
Clinical Trials at University of California at Irvine Medical Center; Department of Oncology
During the past decade, University of California at Irvine Medical Center; Department of Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at University of California at Irvine Medical Center; Department of Oncology
According to Clinical.Site data, the most researched conditions in "University of California at Irvine Medical Center; Department of Oncology" are
"Advanced BRAFV600 Wild-type Melanoma" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "University of California at Irvine Medical Center; Department of Oncology" in a lesser frequency.
Clinical Trials Intervention Types at University of California at Irvine Medical Center; Department of Oncology
Most popular intervention types in "University of California at Irvine Medical Center; Department of Oncology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials), "Bevacizumab" (1 trials), "Cobimetinib" (1 trials) and "Pembrolizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of California at Irvine Medical Center; Department of Oncology
The vast majority of trials in "University of California at Irvine Medical Center; Department of Oncology" are
2 trials for "All" genders.
Clinical Trials Status at University of California at Irvine Medical Center; Department of Oncology
Currently, there are NaN active trials in "University of California at Irvine Medical Center; Department of Oncology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in University of California at Irvine Medical Center; Department of Oncology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University of California at Irvine Medical Center; Department of Oncology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".